Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Emerging Tests-dtet
Diagnostics Pipeline: FDA Approves Visby Medical’s Over-The-Counter Women’s Sexual Health Test
It’s the first PCR-based sexually transmitted infection test platform for at-home use
Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Improving the Chances of Early Breast Cancer Detection in High-Risk Patients
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
New Urine Test Can Detect Synthetic Cannabinoids in Marijuana
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
CMS to Create New Breakthrough Device Medicare Coverage Rule
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Blood Test Can Reliably Predict Patient Risk of Long COVID
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
Is an Antibody Test for Early Detection of Lyme Disease Feasible?
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
AI and Wearable Devices Offer Promise as an Early COVID-19 ID Method
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
Blood-Based Alzheimer’s Tests Have Officially Arrived
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Does Race Affect Interpretation of Alzheimer’s Blood Test Results?
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Global DTC Genetic Testing Market to Top $1.9B by 2026
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Already a member? Log in here